あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/17 | 2,174 | 2,176 | 2,112 | 2,156 | +11 | +0.5% | 62,500 |
| 2024/09/13 | 2,159 | 2,178 | 2,126 | 2,145 | -30 | -1.4% | 70,300 |
| 2024/09/12 | 2,158 | 2,196 | 2,155 | 2,175 | +6 | +0.3% | 64,700 |
| 2024/09/11 | 2,196 | 2,215 | 2,153 | 2,169 | -37 | -1.7% | 59,800 |
| 2024/09/10 | 2,206 | 2,249 | 2,206 | 2,206 | -21 | -0.9% | 43,100 |
| 2024/09/09 | 2,172 | 2,230 | 2,145 | 2,227 | -34 | -1.5% | 50,400 |
| 2024/09/06 | 2,281 | 2,284 | 2,235 | 2,261 | -23 | -1% | 44,200 |
| 2024/09/05 | 2,250 | 2,319 | 2,244 | 2,284 | +9 | +0.4% | 39,600 |
| 2024/09/04 | 2,235 | 2,299 | 2,221 | 2,275 | -39 | -1.7% | 69,600 |
| 2024/09/03 | 2,286 | 2,321 | 2,266 | 2,314 | +13 | +0.6% | 52,700 |
| 2024/09/02 | 2,347 | 2,350 | 2,295 | 2,301 | -61 | -2.6% | 42,000 |
| 2024/08/30 | 2,336 | 2,366 | 2,315 | 2,362 | +37 | +1.6% | 36,500 |
| 2024/08/29 | 2,319 | 2,351 | 2,300 | 2,325 | +6 | +0.3% | 45,700 |
| 2024/08/28 | 2,311 | 2,336 | 2,285 | 2,319 | -6 | -0.3% | 29,500 |
| 2024/08/27 | 2,245 | 2,325 | 2,216 | 2,325 | +68 | +3% | 40,200 |
| 2024/08/26 | 2,306 | 2,342 | 2,246 | 2,257 | -69 | -3% | 44,600 |
| 2024/08/23 | 2,328 | 2,340 | 2,304 | 2,326 | +7 | +0.3% | 42,900 |
| 2024/08/22 | 2,302 | 2,327 | 2,276 | 2,319 | +17 | +0.7% | 44,000 |
| 2024/08/21 | 2,287 | 2,340 | 2,287 | 2,302 | ±0 | ±0% | 30,600 |
| 2024/08/20 | 2,275 | 2,330 | 2,273 | 2,302 | -7 | -0.3% | 75,300 |
| 2024/08/19 | 2,311 | 2,365 | 2,290 | 2,309 | +21 | +0.9% | 79,400 |
| 2024/08/16 | 2,271 | 2,311 | 2,230 | 2,288 | +44 | +2% | 51,300 |
| 2024/08/15 | 2,240 | 2,271 | 2,230 | 2,244 | +54 | +2.5% | 63,000 |
| 2024/08/14 | 2,200 | 2,209 | 2,152 | 2,190 | +69 | +3.3% | 45,300 |
| 2024/08/13 | 2,096 | 2,136 | 2,089 | 2,121 | +30 | +1.4% | 31,100 |
| 2024/08/09 | 2,096 | 2,115 | 2,052 | 2,091 | +45 | +2.2% | 66,100 |
| 2024/08/08 | 2,025 | 2,102 | 2,004 | 2,046 | -2 | -0.1% | 63,300 |
| 2024/08/07 | 2,007 | 2,127 | 2,002 | 2,048 | -29 | -1.4% | 60,700 |
| 2024/08/06 | 1,929 | 2,144 | 1,906 | 2,077 | +148 | +7.7% | 133,700 |
| 2024/08/05 | 2,068 | 2,119 | 1,914 | 1,929 | -275 | -12.5% | 157,200 |
| 2024/08/02 | 2,210 | 2,287 | 2,188 | 2,204 | -42 | -1.9% | 143,800 |
| 2024/08/01 | 2,315 | 2,324 | 2,230 | 2,246 | -119 | -5% | 52,400 |
| 2024/07/31 | 2,267 | 2,365 | 2,262 | 2,365 | +78 | +3.4% | 49,300 |
| 2024/07/30 | 2,288 | 2,303 | 2,270 | 2,287 | -26 | -1.1% | 48,800 |
| 2024/07/29 | 2,322 | 2,327 | 2,290 | 2,313 | +31 | +1.4% | 50,300 |
| 2024/07/26 | 2,335 | 2,353 | 2,282 | 2,282 | -53 | -2.3% | 57,800 |
| 2024/07/25 | 2,371 | 2,373 | 2,335 | 2,335 | -19 | -0.8% | 60,800 |
| 2024/07/24 | 2,361 | 2,378 | 2,338 | 2,354 | -13 | -0.5% | 49,800 |
| 2024/07/23 | 2,410 | 2,410 | 2,361 | 2,367 | -16 | -0.7% | 32,100 |
| 2024/07/22 | 2,430 | 2,430 | 2,383 | 2,383 | -4 | -0.2% | 48,300 |
| 2024/07/19 | 2,382 | 2,405 | 2,375 | 2,387 | +14 | +0.6% | 34,800 |
| 2024/07/18 | 2,365 | 2,398 | 2,363 | 2,373 | -2 | -0.1% | 59,800 |
| 2024/07/17 | 2,398 | 2,403 | 2,358 | 2,375 | -23 | -1% | 70,500 |
| 2024/07/16 | 2,425 | 2,430 | 2,383 | 2,398 | -23 | -1% | 56,400 |
| 2024/07/12 | 2,380 | 2,443 | 2,370 | 2,421 | +21 | +0.9% | 51,900 |
| 2024/07/11 | 2,411 | 2,425 | 2,359 | 2,400 | ±0 | ±0% | 60,500 |
| 2024/07/10 | 2,405 | 2,413 | 2,374 | 2,400 | -11 | -0.5% | 63,900 |
| 2024/07/09 | 2,419 | 2,447 | 2,388 | 2,411 | +13 | +0.5% | 64,200 |
| 2024/07/08 | 2,420 | 2,420 | 2,390 | 2,398 | -21 | -0.9% | 57,800 |
| 2024/07/05 | 2,403 | 2,428 | 2,400 | 2,419 | -3 | -0.1% | 42,000 |
151～
200
件表示中 / 999件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 230,000円 | +0.3% | +2.7% | 2.17% | 13.05倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 221,700円 | +0.4% | -8.4% | 2.39% | 28.46倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 91,600円 | +22.8% | - | 0.00% | 74.84倍 | 1.20倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 49,700円 | -23.0% | - | 4.02% | - | 1.07倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ハートシード | 263,700円 | +174.2% | - | 0.00% | - | 8.98倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
